Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 5
2005 3
2006 1
2007 5
2008 6
2009 5
2010 3
2011 2
2012 2
2013 1
2014 3
2015 3
2016 4
2017 10
2018 8
2019 2
2020 6
2021 8
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Senolytic CAR T cells reverse senescence-associated pathologies.
Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D, Mansilla-Soto J, Boyer JA, Li X, Giavridis T, Kulick A, Houlihan S, Peerschke E, Friedman SL, Ponomarev V, Piersigilli A, Sadelain M, Lowe SW. Amor C, et al. Among authors: ponomarev v. Nature. 2020 Jul;583(7814):127-132. doi: 10.1038/s41586-020-2403-9. Epub 2020 Jun 17. Nature. 2020. PMID: 32555459 Free PMC article.
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma.
Fernández de Larrea C, Staehr M, Lopez AV, Ng KY, Chen Y, Godfrey WD, Purdon TJ, Ponomarev V, Wendel HG, Brentjens RJ, Smith EL. Fernández de Larrea C, et al. Among authors: ponomarev v. Blood Cancer Discov. 2020 Sep;1(2):146-154. doi: 10.1158/2643-3230.BCD-20-0020. Blood Cancer Discov. 2020. PMID: 33089218 Free PMC article.
Editorial to the Special Issue Entitled "Imaging in Immunooncology".
Fruhwirth GO, Weigelin B, Daldrup-Link HE, Ponomarev V. Fruhwirth GO, et al. Among authors: ponomarev v. Mol Imaging Biol. 2022 Apr;24(2):177-180. doi: 10.1007/s11307-022-01719-z. Mol Imaging Biol. 2022. PMID: 35303206 Free PMC article. No abstract available.
Author Correction: Senolytic CAR T cells reverse senescence-associated pathologies.
Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D, Mansilla-Soto J, Boyer JA, Li X, Giavridis T, Kulick A, Houlihan S, Peerschke E, Friedman SL, Ponomarev V, Piersigilli A, Sadelain M, Lowe SW. Amor C, et al. Among authors: ponomarev v. Nature. 2024 Mar;627(8004):E9. doi: 10.1038/s41586-024-07197-3. Nature. 2024. PMID: 38383793 No abstract available.
Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective.
Helfer BM, Ponomarev V, Patrick PS, Blower PJ, Feitel A, Fruhwirth GO, Jackman S, Pereira Mouriès L, Park MVDZ, Srinivas M, Stuckey DJ, Thu MS, van den Hoorn T, Herberts CA, Shingleton WD. Helfer BM, et al. Among authors: ponomarev v. Cytotherapy. 2021 Sep;23(9):757-773. doi: 10.1016/j.jcyt.2021.02.005. Epub 2021 Apr 6. Cytotherapy. 2021. PMID: 33832818 Free PMC article. Review.
Nuclear imaging of cancer cell therapies.
Ponomarev V. Ponomarev V. J Nucl Med. 2009 Jul;50(7):1013-6. doi: 10.2967/jnumed.109.064055. Epub 2009 Jun 12. J Nucl Med. 2009. PMID: 19525449 Free PMC article. Review.
Predicting CAR-T cell Immunotherapy Success through ImmunoPET.
Volpe A, Nagle VL, Lewis JS, Ponomarev V. Volpe A, et al. Among authors: ponomarev v. Clin Cancer Res. 2021 Feb 15;27(4):911-912. doi: 10.1158/1078-0432.CCR-20-4297. Epub 2020 Dec 16. Clin Cancer Res. 2021. PMID: 33328345 Free PMC article.
82 results